SCHEMBL4024217

SCHEMBL4024217

CC(C(Br)Br)S(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30896661 0.78 KDM4E (0.42)
SCHEMBL1579249 0.74
SCHEMBL20640398 0.74
SCHEMBL25481711 0.72
SCHEMBL1705193 0.72
SCHEMBL25481710 0.72
SCHEMBL3377847 0.71
SCHEMBL2446519 0.70
SCHEMBL17322566 0.70
SCHEMBL9484605 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1701948-A4 ASSAY FOR ENTACTOGENS SIEMENS HEALTHCARE DIAGNOSTICS (US) 2009-03-04 EP disclosed
EP-1756570-A4 IMMUNOASSAYS FOR BUPRENORPHINE AND NORBUPRENORPHINE DADE BEHRING INC (US) 2008-05-21 EP disclosed
EP-1701949-A4 ASSAY FOR ENTACTOGENS DADE BEHRING INC (US) 2008-02-20 EP disclosed
EP-1756570-A2 IMMUNOASSAYS FOR BUPRENORPHINE AND NORBUPRENORPHINE DADE BEHRING INC. (US) 2007-02-28 EP disclosed
EP-1701948-A1 ASSAY FOR ENTACTOGENS DADE BEHRING INC. (US) 2006-09-20 EP disclosed
EP-1701949-A2 ASSAY FOR ENTACTOGENS DADE BEHRING INC. (US) 2006-09-20 EP disclosed
WO-2005103697-A2 IMMUNOASSAYS FOR BUPRENORPHINE AND NORBUPRENORPHINE DADE BEHRING INC. (US) 2005-11-03 WO disclosed
WO-2005058864-A1 ASSAY FOR ENTACTOGENS DADE BEHRING INC. (US) 2005-06-30 WO disclosed
WO-2005058865-A2 ASSAY FOR ENTACTOGENS DADE BEHRING INC. (US) 2005-06-30 WO disclosed